Phase 2 clinical trial of the AVI-CO-004 tablet.

Trial Profile

Phase 2 clinical trial of the AVI-CO-004 tablet.

Phase of Trial: Phase II

Latest Information Update: 20 Mar 2018

At a glance

  • Drugs AVI CO 004 (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2018 New trial record
    • 03 Mar 2018 According to Ebixen media release, the Korea Food and Drug Administration (KFDA) approved AVI-CO-004 for phase 2 study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top